Later, along the same lines as the previous two groups, Gottschlich et al., with 109 head and neck cancer patients, observed that s-p53-abs correlated with worse outcomes, although the authors did not show any statistical significance in their data [137]. This evidence concerns the gene TP53 and head and neck cancer.